The Beekly: Inside Cencora's Latest Sustainability Report

​Cencora just released its FY25 Annual Corporate Responsibility Report — its 10th annual report. For a company operating at the center of the global pharmaceutical supply chain, the climate and sustainability stakes are real: supply continuity for life-saving medications, a massive Scope 3 footprint concentrated in suppliers, and growing regulatory exposure across climate disclosure frameworks.

​In this episode, Beehive CEO Adriel Lubarsky sits down with Cencora's Global Corporate Responsibility Reporting & Operations Director Laura Sugam to unpack what the report actually says, and what actions it will lead to. We will dig into Cencora's recent base year recalculation, their plan to drive value from this report, and how the company is framing physical risk and supply chain resilience — from backup power at distribution facilities to emergency preparedness protocols for extreme weather events.

​We also ask the harder questions: How does a Fortune 10 pharmaceutical distributor quantify climate-related financial risk in its operations? What is it like to prepare a 99-page corporate responsibility report? And what change does a report like this actually lead to?

​If you're tracking where large-cap industrials are on the climate disclosure curve — and what a mature report still can improve — this is the conversation.